How Do Biotechnology Firms Contribute to Cancer Diagnostics?
Biotechnology firms have revolutionized cancer diagnostics through the development of advanced techniques such as liquid biopsies, next-generation sequencing (NGS), and molecular imaging. Liquid biopsies, for instance, allow for the detection of cancer-related biomarkers in blood samples, enabling early diagnosis and monitoring of disease progression. NGS provides detailed genetic information about tumors, helping to tailor personalized treatment plans. Molecular imaging enhances the ability to visualize tumors, improving the accuracy of diagnosis and treatment planning.
